MedTrace Logo

Effects of GS-3K8 and GINst15 on Acute Respiratory Illness

NCT03028077 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2017-01-23

No results posted yet for this study

Summary

This study was conducted to investigate the effects of daily supplementation of GS-3K8 or GINst15 on acute respiratory illness (ARI) in healthy subjects.

Conditions

  • Acute Respiratory Infection

Interventions

DIETARY_SUPPLEMENT

GS-3K8

GS-3K8 (ultrafiltered red ginseng extract) 1 g/day

DIETARY_SUPPLEMENT

GINst15

GINst15 (hydrolyzed ginseng extract) 1 g/day

DIETARY_SUPPLEMENT

Placebo

Placebo 1 g/day

Sponsors & Collaborators

  • Chonbuk National University Hospital

    lead OTHER

Principal Investigators

  • Jeong Hwan Hwang, M.D. Ph. D · Chonbuk National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
39 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03028077 on ClinicalTrials.gov